Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
P1.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.01-21 - Safety of Durvalumab Retreatment in Advanced NSCLC Patients Who Progressed Following Initial Disease Control In ATLANTIC
16:45 - 18:00 | Presenter: Marina Chiara Garassino | Author(s): Byoung Chul Cho, Joo-Hang Kim, Julien Mazieres, Johan F. Vansteenkiste, Hervé Lena, Jesus Corral, Jhanelle Elaine Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross Soo, Yifan Huang, Catherine Wadsworth, Phillip A. Dennis, Naiyer A Rizvi
- Abstract
Loading...
-
+
MS14 - IO in Early Stage NSCLC
- 10:30 - 12:00
- 9/25/2018
- Location: Room 107
- Type: Mini Symposium
- Track: Immunooncology
-
+
MS14.05 - Do Biomarkers used in Metastatic Setting Apply in Earlier Stages
11:30 - 11:45 | Presenter: Naiyer A Rizvi
- Abstract
No abstract available for this presentation
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-33 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1 Containing Therapy (HUDSON)
16:45 - 18:00 | Presenter: Patrick M Forde | Author(s): John V Heymach, Michael Thomas, Keunchil Park, Benjamin Besse, Mark M. Awad, Glenwood Goss, Naiyer A Rizvi, Helen J Ambrose, Philip John Jewsbury, Barbara Koetz, Si-Houy Lao-Sirieix, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, Wolfram Brugger
- Abstract
Loading...
-
+
P2.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.17-27 - IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab + Chemotherapy
16:45 - 18:00 | Presenter: Naiyer A Rizvi | Author(s): David R. Gandara, Ben J Solomon, Anthony W. Kim, Alessandro Brunelli, Shawn W. Sun, Barbara J Gitlitz, Kosei Tajima, Wei Lin, Alan Sandler, Solange Peters
- Abstract
Loading...
-
+
EX04 - Mini Oral Abstract Session - MA08.06, MA18.02, MA19.02, MA20.11
- 09:55 - 10:25
- 9/26/2018
- Location: Exhibit Showcase Theater
- Type: Exhibit Showcase
- Track: Advanced NSCLC
-
+
EX04.03 - Prior Therapy and Increased Expression of PD-L1 in NSCLC Tumor Samples
10:05 - 10:10 | Presenter: Anne-Marie Boothman | Author(s): Marietta Scott, Marianne Ratcliffe, Jessica Whiteley, Phillip A. Dennis, Catherine Wadsworth, Alan Sharpe, Naiyer A Rizvi, Marina Chiara Garassino, Jill Walker
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.04-23 - Phase 1b/2 Study to Evaluate Novel Combinations With Oleclumab (MEDI9447) in Previously Treated Advanced EGFRm NSCLC
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Catherine Shu, Sarah B Goldberg, Vassiliki A Papadimitrakopoulou, Ross Camidge, Sandip Patel, Kristen A. Marrone, Sang-We Kim, Dong-Wan Kim, Hsin-ju Hsieh, Nancy Mueller, Rakesh Kumar, Judson Englert, Keunchil Park
- Abstract
Loading... -
+
P3.04-24 - EMPOWER-Lung 2: Cemiplimab and Ipilimumab ± Chemotherapy vs Pembrolizumab in Advanced NSCLC with PD-L1 ≥50%, a Phase 3 Study
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Sue Lee, Paul Curtis, Wilson Caldwell, Bo Gao, Petra Rietschel
- Abstract
Loading... -
+
P3.04-25 - EMPOWER-Lung 3: A Phase 3 Study of Cemiplimab, Ipilimumab and Chemotherapy in Advanced NSCLC with PD-L1 <50%
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Sue Lee, Paul Curtis, Wilson Caldwell, Bo Gao, Petra Rietschel
- Abstract
Loading... -
+
P3.04-26 - EMPOWER-Lung 4: A Phase 2 Study of Cemiplimab Plus Ipilimumab in the Second-Line Treatment of Advanced NSCLC with PD-L1 <50%
12:00 - 13:30 | Presenter: Naiyer A Rizvi | Author(s): Sue Lee, Paul Curtis, Wilson Caldwell, Bo Gao, Petra Rietschel
- Abstract
Loading...